Can We Stop Reflexively Discontinuing Mineralocorticoid Antagonists for Patients With Heart Failure and Hyperkalemia?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can We Stop Reflexively Discontinuing Mineralocorticoid Antagonists for Patients With Heart Failure and Hyperkalemia?
Authors
Keywords
-
Journal
JOURNAL OF CARDIAC FAILURE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-06-10
DOI
10.1016/j.cardfail.2022.05.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
- (2022) Brendon L. Neuen et al. CIRCULATION
- Accelerated and personalized therapy for heart failure with reduced ejection fraction
- (2022) Li Shen et al. EUROPEAN HEART JOURNAL
- 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
- (2022) Paul A. Heidenreich et al. JOURNAL OF CARDIAC FAILURE
- Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction
- (2022) João Pedro Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- IS STOPPING MINERALOCORTICOID RECEPTOR ANTAGONISTS AFTER HYPERKALEMIA ASSOCIATED WITH INCREASED MORTALITY IN HEART FAILURE? A SYSTEMATIC REVIEW AND META-ANALYSIS
- (2022) Tariq Jamal Siddiqi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists
- (2021) Li Shen et al. JACC-Heart Failure
- Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care
- (2021) Marco Trevisan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial
- (2021) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction
- (2021) Vishal N. Rao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
- (2020) Matteo Serenelli et al. JACC-Heart Failure
- Abnormalities of Potassium in Heart Failure
- (2020) João Pedro Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology
- (2019) Wilfried Mullens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Hyperkalemia Is Associated With Increased Mortality Among Unselected Cardiac Intensive Care Unit Patients
- (2019) Benjamin Brueske et al. Journal of the American Heart Association
- Medical Therapy for Heart Failure With Reduced Ejection Fraction
- (2018) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sodium Zirconium Cyclosilicate in Hyperkalemia
- (2015) David K. Packham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist
- (2014) Orly Vardeny et al. Circulation-Heart Failure
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction
- (2011) Patrick Rossignol et al. CIRCULATION
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
- (2008) Bertram Pitt et al. CIRCULATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started